Cevimeline is a cholinergic agonist that primarily stimulates muscarinic receptors, which are part of the parasympathetic nervous system. It is commonly prescribed for patients suffering from dry mouth, particularly those with Sjögren's syndrome, an autoimmune condition affecting the moisture-producing glands.